Biotech Company Cara Therapeutics (CARA) Up 15%

MarketsETF Trends

This article was originally published on

Despite the sea of red in U.S. markets today, one stock that has been showing stellar gain is biotech company Cara Therapeutics (CARA). Cara, a biotech that has been developing treatments for itchiness, rose 12.6% in pre-market trade Wednesday after the company released studies that dialysis patients experiencing itchiness who were given its Korsuva injection [...]

Continue Reading Below

Read more at >